Total Payments
$14,239
2024 Payments
$896.37
Companies
16
Transactions
107
Medicare Patients
2,536
Medicare Billing
$456,601
Payment Breakdown by Category
Research$10,482 (73.6%)
Food & Beverage$2,638 (18.5%)
Travel$1,119 (7.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $10,482 | 17 | 73.6% |
| Food and Beverage | $2,638 | 84 | 18.5% |
| Travel and Lodging | $1,119 | 6 | 7.9% |
Payments by Type
Research
$10,482
17 transactions
General
$3,757
90 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk AS | $9,900 | 15 | $0 (2019) |
| Janssen Research & Development, LLC | $921.54 | 8 | $0 (2023) |
| ABBVIE INC. | $736.10 | 48 | $0 (2024) |
| Imperative Care, Inc | $678.23 | 10 | $0 (2024) |
| GUERBET LLC | $582.40 | 2 | $0 (2021) |
| Penumbra, Inc. | $454.39 | 5 | $0 (2021) |
| Stryker Corporation | $208.61 | 5 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $120.01 | 1 | $0 (2021) |
| Edwards Lifesciences Corporation | $116.32 | 1 | $0 (2019) |
| Novo Nordisk Inc | $112.22 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $896.37 | 26 | Imperative Care, Inc ($645.03) |
| 2023 | $1,241 | 28 | Janssen Research & Development, LLC ($921.54) |
| 2022 | $398.27 | 18 | ABBVIE INC. ($210.83) |
| 2021 | $1,028 | 8 | GUERBET LLC ($582.40) |
| 2020 | $42.96 | 3 | Stryker Corporation ($16.21) |
| 2019 | $3,576 | 6 | Novo Nordisk AS ($3,375) |
| 2018 | $6,844 | 16 | Novo Nordisk AS ($6,525) |
| 2017 | $213.62 | 2 | Penumbra, Inc. ($194.00) |
All Payment Transactions
107 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $11.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/05/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.77 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $10.60 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.81 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/03/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/20/2024 | Imperative Care, Inc | ZOOM REPERFUSION CATHETER (Device) | Food and Beverage | In-kind items and services | $31.98 | General |
| Category: VASCULAR | ||||||
| 09/20/2024 | Imperative Care, Inc | ZOOM REPERFUSION CATHETER (Device) | Food and Beverage | In-kind items and services | $22.84 | General |
| Category: VASCULAR | ||||||
| 09/19/2024 | Imperative Care, Inc | ZOOM 88-T LARGE DISTAL PLATFORM (Device) | Food and Beverage | In-kind items and services | $68.17 | General |
| Category: VASCULAR | ||||||
| 09/19/2024 | Imperative Care, Inc | ZOOM 88-T LARGE DISTAL PLATFORM (Device) | Food and Beverage | In-kind items and services | $9.05 | General |
| Category: VASCULAR | ||||||
| 09/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $112.22 | General |
| 08/23/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $7.46 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/16/2024 | Imperative Care, Inc | ZOOM 88-T LARGE DISTAL PLATFORM (Device) | Travel and Lodging | In-kind items and services | $40.75 | General |
| Category: VASCULAR | ||||||
| 08/16/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $6.65 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Imperative Care, Inc | ZOOM 88-T LARGE DISTAL PLATFORM (Device) | Travel and Lodging | In-kind items and services | $414.96 | General |
| Category: VASCULAR | ||||||
| 08/09/2024 | Imperative Care, Inc | ZOOM 88-T LARGE DISTAL PLATFORM (Device) | Travel and Lodging | In-kind items and services | $31.25 | General |
| Category: VASCULAR | ||||||
| 07/19/2024 | ABBVIE INC. | QULIPTA (Drug), BOTOX | Food and Beverage | In-kind items and services | $4.21 | General |
| Category: NEUROSCIENCE | ||||||
| 07/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $3.89 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $2.33 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.01 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/20/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/22/2024 | Imperative Care, Inc | ZOOM 88-T LARGE DISTAL PLATFORM (Device) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: VASCULAR | ||||||
| 02/10/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: NEUROSCIENCE | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| NN9924-4221 | Novo Nordisk AS | $5,625 | 3 |
| NN9535-4270 | Novo Nordisk AS | $1,350 | 2 |
| NN9535-4114 | Novo Nordisk AS | $675.00 | 3 |
| NN9924-4223 | Novo Nordisk AS | $675.00 | 1 |
| Prospective Evaluation of Potential Effects of Repeated Gadolinium-based Contrast Agent (GBCA) Administrations of the Same GBCA on Motor and Cognitive Functions in Neurologically Normal Adults in Comparison to a Non-GBCA Exposed Control Group | GUERBET LLC | $582.40 | 2 |
| NN9924-4257 | Novo Nordisk AS | $450.00 | 2 |
| NN9924-4282 | Novo Nordisk AS | $450.00 | 1 |
| NN9924-4222 | Novo Nordisk AS | $225.00 | 1 |
| NN9924-4234 | Novo Nordisk AS | $225.00 | 1 |
| NN9924-4280 | Novo Nordisk AS | $225.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 524 | 765 | $734,597 | $100,883 |
| 2022 | 11 | 536 | 771 | $742,545 | $92,964 |
| 2021 | 14 | 689 | 943 | $739,231 | $116,515 |
| 2020 | 18 | 787 | 1,092 | $960,424 | $146,240 |
Total Patients
2,536
Total Services
3,571
Medicare Billing
$456,601
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 106 | 301 | $48,160 | $17,844 | 37.1% |
| 37215 | Insertion of stent and blood clot protection device in neck artery with review by radiologist | Facility | 2023 | 20 | 23 | $68,839 | $16,961 | 24.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 127 | 128 | $56,960 | $16,130 | 28.3% |
| 36223 | Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | Facility | 2023 | 48 | 54 | $256,838 | $11,731 | 4.6% |
| 36226 | Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | Facility | 2023 | 43 | 47 | $213,751 | $10,125 | 4.7% |
| 61645 | Removal of blood clot and injection to dissolve blood clot from head artery using fluoroscopic guidance | Facility | 2023 | 15 | 15 | $36,426 | $9,605 | 26.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 59 | 60 | $14,100 | $5,032 | 35.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 43 | 49 | $15,445 | $4,836 | 31.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 46 | $10,580 | $4,248 | 40.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 15 | 15 | $6,618 | $2,103 | 31.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $4,800 | $1,514 | 31.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 11 | $2,081 | $755.10 | 36.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 121 | 332 | $53,120 | $18,244 | 34.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 122 | 124 | $55,180 | $18,045 | 32.7% |
| 36223 | Insertion of tube into intracranial artery for diagnosis or treatment with review by radiologist | Facility | 2022 | 54 | 54 | $227,129 | $14,302 | 6.3% |
| 37215 | Insertion of stent and blood clot protection device in neck artery with review by radiologist | Facility | 2022 | 14 | 15 | $44,895 | $11,420 | 25.4% |
| 36226 | Insertion of tube into brain artery for diagnosis or treatment with review by radiologist | Facility | 2022 | 44 | 46 | $202,956 | $8,715 | 4.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 49 | 54 | $10,640 | $5,599 | 52.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 55 | 55 | $12,100 | $4,510 | 37.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 28 | 28 | $7,200 | $4,033 | 56.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 35 | $8,050 | $2,807 | 34.9% |
| 36224 | Insertion of tube into internal neck artery for diagnosis or treatment with review by radiologist | Facility | 2022 | 11 | 11 | $58,401 | $2,707 | 4.6% |
| 36225 | Insertion of tube into chest artery for diagnosis or treatment with review by radiologist | Facility | 2022 | 17 | 17 | $62,874 | $2,582 | 4.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 157 | 160 | $69,400 | $24,308 | 35.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 146 | 337 | $52,905 | $18,886 | 35.7% |
About Dr. Amer Alshekhlee, MD
Dr. Amer Alshekhlee, MD is a Neurology healthcare provider based in Bridgeton, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255328100.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amer Alshekhlee, MD has received a total of $14,239 in payments from pharmaceutical and medical device companies, with $896.37 received in 2024. These payments were reported across 107 transactions from 16 companies. The most common payment nature is "" ($10,482).
As a Medicare-enrolled provider, Alshekhlee has provided services to 2,536 Medicare beneficiaries, totaling 3,571 services with total Medicare billing of $456,601. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Other Specialties Neurology, Vascular Neurology
- Location Bridgeton, MO
- Active Since 10/05/2005
- Last Updated 05/29/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1255328100
Products in Payments
- Ozempic (Drug) $1,800
- BOTOX (Biological) $653.38
- ZOOM 88-T LARGE DISTAL PLATFORM (Device) $623.41
- Indigo (Device) $194.00
- Penumbra SMART Coil (Device) $121.37
- BRILINTA (Drug) $120.01
- Penumbra System (Device) $119.40
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $116.32
- DALVANCE (Drug) $100.00
- DUPIXENT (Biological) $99.55
- SURPASS EVOLVE (Device) $95.89
- LifeVest (Device) $91.84
- TARGET (Device) $84.44
- Quadra Assura CRT Defibrillator (Device) $77.02
- ZOOM REPERFUSION CATHETER (Device) $54.82
- STENT (Device) $19.64
- LVIS Jr. (Device) $19.62
- TREVO (Device) $16.21
- Sofia 6F-125cm STR (Device) $15.59
- UBRELVY (Drug) $15.48
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Bridgeton
Dr. Siddharth Kaul, Md, MD
Neurology — Payments: $552,004
Neurology $552,004
Dr. Daniel Mattson, Md, MD
Neurology — Payments: $500,463
Neurology $500,463
Dr. Seth Hepner, Md, MD
Neurology — Payments: $251,257
Neurology $251,257
Dr. Xinrong Lu, M.d, M.D
Neurology — Payments: $22,610
Neurology $22,610
Dr. Chizoba Ezepue, Md, MD
Neurology — Payments: $5,505
Neurology $5,505
Dr. Robert Margolis, M.d, M.D
Neurology — Payments: $3,305
Neurology $3,305